PERSPECTA

News from every angle

Back to headlines

Candel Therapeutics Shares Surge to 52-Week High

The biotechnology company sees its stock reach $13.96, reflecting renewed investor confidence in its clinical pipeline and therapeutic development progress.

27 Aug, 14:57 — 27 Aug, 14:57
PostShare

Sources

Showing 1 of 1 sources